Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of hospital-acquired and life-threatening infections. Active surveillance programs for MRSA utilize either molecular or culture-based methods. A prospective study was performed to compare the performance of selective and differential chromogenic media, BBL CHROMagar MRSA II (CMRSA II; BD Diagnostics, Sparks, MD), MRSASelect (Bio-Rad Laboratories, Redmond, WA), and Spectra MRSA (Remel, Lenexa, KS), for the detection of MRSA in nasal swab specimens. A total of 515 compliant remnant nasal swab specimens were sequentially used to inoculate BBL Trypticase soy agar with 5% sheep blood (TSA II) and each chromogenic medium. After 24 h of incubation, colony color reactions and morphology on chromogenic media were compared to suspicious colonies on nonselective TSA II. MRSA on TSA II was confirmed by Gram staining, a coagulase test, and a cefoxitin disk test. The overall prevalence of MRSA and methicillin-susceptible S. aureus (MSSA) on TSA II was 12.4% (64/515) and 9.7% (50/515), respectively. When each chromogenic medium was compared to the standard culture method, the sensitivity and specificity, respectively, were as follows: CMRSA II, 87.7% and 98.6%; MRSASelect, 89.0% and 93.4%; and Spectra MRSA, 83.6% and 92.1%. The positive predictive values were highest for CMRSA II (91.4%), followed by MRSASelect (69.1%) and Spectra MRSA (63.5%). False-positive results on chromogenic media were mainly due to color interpretation. The negative predictive values for all three media were greater than 97%. In conclusion, CMRSA II gave the best overall results for detecting MRSA from nasal specimens.
Methicillin-resistant Staphylococcus aureus (MRSA) is the most common cause of hospital-associated infections. To control the transmission of MRSA in health care facilities, targeted active surveillance cultures and an active infection control program to eliminate or control the spread of MRSA in hospitals are recommended (1, 2). The introduction of molecular methods (e.g., PCR) for the detection of MRSA in nasal specimens has improved the reporting time of MRSA and utilization of infection control resources (3-5). However, not all laboratories can justify the added expense of molecular methods. An alternative, costeffective approach is the use of chromogenic media for screening nasal specimens for MRSA carriage. BBL CHROMagar MRSA II (CMRSA II, BD), MRSASelect (Bio-Rad), and Spectra MRSA (Remel) are selective and differential chromogenic media for the qualitative detection of MRSA from nasal surveillance specimens. Each contains specific chromogenic substrates, antimicrobials, and selective agents for the suppression of Gram-negative organisms, yeasts, and other Gram-positive cocci. Identification of MRSA from the primary culture is based on the cleavage of chromogenic substrate by a specific enzymatic activity of S. aureus, leading to coloration of colonies. A three-way comparison study was conducted to determine the performance characteristics of these commercially av...